A nine-institution team led by Carnegie Mellon University (CMU), and including the Children’s Hospital of Philadelphia (CHOP), has secured an award of up to $39.3 million from the Advanced Research ...

Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the ...

Gene and cell therapies are reshaping the treatment landscape for inherited, degenerative, and acquired disorders. Yet successful translation depends on ...

Use of automated insulin delivery technology improves a Healthcare Effectiveness Data and Information Set quality measure in individuals with type 2 diabetes. Objective: To evaluate the effect of ...

Lilac Biosciences Inc., a life sciences company spun out of the Giuliani RNA Center at Brown University, and Soin Neuroscience today announced the publication of a joint clinical review in Frontiers ...

All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - - Independent Safety Monitoring Committee to review Cohort 1 safety ...

Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications ...

All eight patients enrolled and dosed in Cohort 1 ahead of previously disclosed guidance of the end of the third quarter of 2026 - ...

Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejection Serial monitoring of patients through donor-derived cell-free ...